SCHEMBL19009627

SCHEMBL19009627

c1ccc(C2(c3ccccc3)c3ccc(-c4ccc(-c5ncccn5)cc4)cc3-c3cc(-c4ccc(-c5ncccn5)cc4)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.36
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
MEN1 O00255 4/20 0.36
MAPT P10636 4/20 0.36
KMT2A Q03164 4/20 0.36
CLK4 Q9HAZ1 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ADRB2 P07550 1/20 0.36
OPRK1 P41145 1/20 0.36
TYRO3 Q06418 1/20 0.34
NTRK2 Q16620 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
HDAC4 P56524 1/20 0.33
PIK3CA P42336 1/20 0.32
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29393750 0.89 MEN1 (0.46) SMN1; SMN2MEN1MAPTKMT2ACLK4
SCHEMBL21707836 0.85 MEN1 (0.46) SMN1; SMN2NPC1RAB9AMEN1MAPT
SCHEMBL26937598 0.84 MEN1 (0.45) SMN1; SMN2NPC1RAB9AMEN1MAPT
SCHEMBL15977491 0.82 PIK3CA (0.32) MEN1KMT2ACLK4LMNAPIK3CA
SCHEMBL23697579 0.81 MEN1 (0.49) SMN1; SMN2NPC1RAB9AMEN1MAPT
SCHEMBL17887033 0.81 MEN1 (0.49) SMN1; SMN2NPC1RAB9AMEN1MAPT
SCHEMBL31664379 0.81 MEN1 (0.49) SMN1; SMN2NPC1RAB9AMEN1MAPT
SCHEMBL22037581 0.81 MEN1 (0.49) SMN1; SMN2NPC1RAB9AMEN1MAPT
SCHEMBL19885853 0.81 MEN1 (0.42) SMN1; SMN2MEN1MAPTKMT2ALMNA
SCHEMBL17887084 0.81 MEN1 (0.49) SMN1; SMN2NPC1RAB9AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 SMN1; SMN2 4133/4885NPC1 317/4885RAB9A 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.